eMedicine Specialties > Infectious Diseases > Viral Infections

Echoviruses

Author: Mary T Busowski, MD, Fellow in Infectious Diseases, Orlando Health; Clinical Instructor of Medicine, Florida State University School of Medicine
Coauthor(s): Mark R Wallace, MD, FACP, FIDSA, Clinical Professor of Medicine, Florida State University College of Medicine; Infectious Disease Fellowship Director, Orlando Regional Medical Center; Larry I Lutwick, MD, Professor of Medicine, State University of New York, Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus
Contributor Information and Disclosures

Updated: Nov 25, 2009

Introduction

Background

Echoviruses are members of the Enterovirus genus in the Picornaviridae family. They make up the largest Enterovirus subgroup, consisting of 32 serotypes.1 Echoviruses are common human pathogens that cause a range of illnesses, from minor febrile illness to severe, potentially fatal conditions (eg, aseptic meningitis, encephalitis, paralysis, myocarditis).2,1 Individual serotypes have different temporal patterns of circulation and cause different clinical manifestations. Changes in circulating serotypes can be associated with large scale outbreaks.2

Enteroviruses are divided into 5 subgenera: polioviruses, group A coxsackieviruses, group B coxsackieviruses, echoviruses, and the newer enteroviruses. Each subgenus contains numerous unique enterovirus serotypes differentiated based on neutralization of specific antisera.3

The term enterovirus reflects enteric transmission of the virus via person-to-person spread. ECHO is an acronym for enteric cytopathic human orphan.

Echoviruses were first isolated from the feces of asymptomatic children in the context of epidemiological studies of polioviruses. The viruses produced cytopathic effects in cell cultures but failed to cause detectable pathologic lesions in suckling mice.4 Most echoviruses are no longer considered orphans.

Echoviruses were originally classified into 34 serotypes. Echovirus 10 and 28 have been reclassified as reoviruses, and echovirus 9 is now recognized as the same as coxsackievirus A23.2

Echoviruses are small nonenveloped viruses with an icosahedral configuration. A capsid composed of 60 subunits is formed from 4 proteins—VP1 to VP4. These proteins play important roles in terms of determining host range and tropism and in delivering the RNA genome into the cytoplasm of the host's cells. Echoviruses are infective over a wide range of pH (3-10) and are resistant to ether and alcohol.5

Pathophysiology

Human echoviral infection occurs via fecal-oral transmission. Host susceptibility depends on the presence of specific cellular membrane receptor proteins that bind different enteroviral types along taxonomic lines. Decay-accelerating factor (DAF) appears to be a major echovirus receptor, binding many echovirus serotypes, including 6, 7, 11, 12, 20, 21, 29, and 33. Echovirus serotypes 1 and 8 bind a subunit of the very late antigen (VLA) integrin molecule.

Following ingestion of fecally contaminated material, viral replication begins in the pharynx or gut. The precise site of viral entry and initial replication in the GI tract is not well established, but researchers have demonstrated the presence of enteroviruses in mucosal M cells. Ileal lymphoid tissue demonstrates enteroviral replication within 1-3 days after ingestion. The maximal duration of viral excretion is 3-4 weeks in the pharynx and 5-6 weeks in stool.

Following replication, enteroviruses spread to regional lymph nodes and cause subclinical transient viremia. During this low-grade viremia, the virus spreads to reticuloendothelial tissues, including the liver, spleen, bone marrow, and distant lymph nodes. Secondary sites of infection include the CNS, liver, spleen, bone marrow, heart, and lungs. More than 90% of echoviral infections are asymptomatic. When disease occurs, symptoms vary from undifferentiated febrile illness to severe illness, depending on the age, gender, and immune status of the host and the subgroup, serotype, and enteroviral strain.6

For additional information, please also refer to eMedicine's Enterovirus topic.

Frequency

United States

Echoviruses are common and are associated with both epidemic and endemic patterns of infection in individuals of all ages.7 The voluntary and passive nature of viral illness reporting complicates the true estimate of disease.2 Serologic surveys are not feasible because of the large number of nonpoliovirus serotypes.

In temperate climates, enteroviral activity peaks during the summer and early fall.8 Serotype-based surveillance provides a mechanism for determining patterns of circulation and for identifying predominant serotypes.2 Changes in predominant serotypes can be associated with large-scale outbreaks of enteroviral illnesses. In 2005, the National Enterovirus Surveillance System (NESS) reported that the 15 most common enteroviruses accounted for 83.5% of reports with identified serotypes. The 5 most common serotypes were echoviruses 9, 11, 30, and 6 and coxsackievirus B5, accounting for 48.1% of reported cases.

In the United States, peaks in nationwide hospitalization for aseptic meningitis have been observed in years when echovirus 9 was predominant. Echovirus 9 was the most commonly reported enterovirus from 1970-2005 and accounted for 11.8% of reports with known serotypes.2

International

Echoviruses are found worldwide and affect people of all races and cultures. Infection rates vary with the season, geography, and the age and socioeconomic status of the population sampled. Infection among lower socioeconomic groups is attributed to overcrowded living conditions and poor hygiene.9 Infections occur throughout the year in tropical climates. In temperate climates, infections are more prevalent during the summer and early fall.9

Epidemics have been reported in Panama, Mexico, Switzerland, Cuba, the United States, and Turkey. Asian-Pacific countries have reported major enteroviral epidemics with significant morbidity and mortality. A Thai hospital reported the first nosocomial outbreak of hand-foot-and-mouth disease due to echovirus type 11, underscoring the importance of strict infection control and hand washing in preventing disease.10 A similar outbreak of echovirus 11 was reported from an Israeli children's home. Nine children shared a large room with a common basin. Three children presented with aseptic meningitis, and all had stool cultures positive for echovirus 11.9

Race

Echovirus infection has no racial predilection.

Sex

For unclear reasons, males are at greater risk for clinical illness following infection, by as much as 50%.11 Aseptic meningitis is nearly twice as common in boys as in girls. After puberty, the reverse appears to be true, perhaps because women tend to have more exposure to children who are shedding the virus. Pregnancy also appears to enhance the severity of enteroviral infections.

Age

Three quarters of enteroviral infections, including echoviral infections, reported to the World Health Organization occur in children younger than 15 years. In the United States, attack rates in infants younger than 1 year greatly exceed those in older children and adults.12,13 Children younger than one year accounted for 44.2% of reported cases. A male predominance was noted among patients younger than 20 years, but not among patients aged 20 years or older.2

Clinical

History

Fifty to eighty percent of patients with echoviral infections are asymptomatic. The most common presentation is a nonfocal, asymptomatic febrile illness. Illnesses may be caused by virtually any enteroviral serotype and are indistinguishable clinically from infection with many other viral agents. Disease syndromes characteristic of enteroviral infections (eg, aseptic meningitis, pericarditis) are, in fact, unusual manifestations of infection.

  • Acute aseptic meningitis
    • Acute aseptic meningitis manifests as signs and symptoms of meningeal irritation and cerebrospinal fluid (CSF) pleocytosis in the absence of bacteria or fungi. CSF cell counts are typically 10-500/µL and may show neutrophil predominance early but invariably shift to a lymphocyte predominance.6
    • The onset may be gradual or abrupt. Echoviral meningitis may have a biphasic pattern. Fever and myalgias with clinical defervescence followed by reappearance of fever and headache herald the onset of meningitis, similar to what is observed in poliomyelitis.
    • Meningismus, when present, varies from mild to severe. Only about one third of patients demonstrate Kernig and Brudzinski signs. Pharyngitis and other symptoms of upper respiratory tract infection are often present.6
    • Complications such as febrile seizures, lethargy, coma, and movement disorders are reported in 5%-10% of cases and may overlap with an encephalitis-type illness. Adults may experience a longer period of fever and illness than younger patients, and those with severe cases may be incapacitated for 1-2 weeks.
  • Encephalitis
    • Encephalitis is a well-described, but rare, manifestation of coxsackievirus and echovirus CNS infection.
    • Symptoms include lethargy, drowsiness, personality changes, seizures, paresis, and coma.
    • Although quite rare, enteroviral CNS infections have been reported to cause an encephalitis lethargica–type picture with oculogyric crisis, cranial nerve palsies, and a parkinsonism-like picture.
  • Rash: Skin rashes are more common with echoviral infections than with other enteroviral infections. Exanthems may be maculopapular, morbilliform, macular, petechial, or papulopustular.
  • Respiratory illness
    • Echovirus, similar to many enteroviruses, may be associated with pyrexial illness (the so-called summer grippe), with sore throat, cough, or coryza.
    • Echovirus 11 can be associated with croup.
  • Herpangina
    • Herpangina is a well-characterized, vesicular, oral mucosal process involving the tonsillar fossa and soft palate. Symptoms include elevated temperature, pharyngitis, and dysphagia.
    • It is commonly observed in summer outbreaks involving younger children, often younger than 10 years, and less common in adolescents and young adults.
    • Herpangina begins abruptly with fevers as high as 104°F and is associated with nonpersistent vomiting, myalgia, and headache. Sore throat and dysphagia are the prominent symptoms and precede the appearance of the oral lesions.
  • Epidemic pleurodynia (Bornholm disease)
    • First described by William Cooper, MD, in 1888, the term "devil's grip" was used to describe cases from an outbreak of fever and chest pain. The illness is characterized by an abrupt onset of fever and sharp spasms of pain involving the intercostal muscles. Pain may also involve abdominal muscles and mimic acute abdomen.
    • Major epidemics have occurred at infrequent 10- to 20-year intervals. It typically affects older adults, with children having a milder course.
    • The illness is usually self-limited, with resolution in most individuals within 1 week. The first episode of pain is usually the most symptomatic. Subsequent episodes tend to be shorter in duration and accompanied by lower temperature elevation. Dull aching of involved muscles may be reported between episodes, but the patient usually appears well between the paroxysms.
    • Most patients recover within a week, but about 25% may experience relapses up to a month after the first attack.
  • Paralysis and other neurologic complications of echovirus infection
    • Paralytic disease caused by nonpolio enteroviruses is usually less prominent than poliovirus-associated paralysis. Muscle weakness is more common than flaccid paralysis and is usually not permanent. Cranial nerve involvement has been reported and usually manifests as oculomotor palsy. Cases of fatal bulbar involvement have been reported.
    • Guillain-Barré syndrome has been reported rarely in patients infected with echovirus serotypes 6 and 22.
    • Transverse myelitis has been reported in a patient with a CSF evaluation positive for echovirus 5.
  • Myocardial/pericardial disease
    • Enteroviral myocarditis is often associated with an upper respiratory tract illness and may occur at any age, but seems to be particularly prominent in adolescents and young adults. Males are affected twice as often as females. In many cases, an upper respiratory tract illness is reported within 2 weeks prior to the onset of cardiac manifestations.
    • Common symptoms include shortness of breath, chest pain, fever, and weakness.

Physical

  • Acute aseptic meningitis
    • The highest rates of clinically recognized aseptic meningitis are reported in infants younger than 3 months. This observation may, in part, be related to the practice of performing lumbar punctures for pyrexia in this age group.
    • Only a small number of the infants have clinical evidence of neurologic disease.
    • Adults with acute aseptic meningitis demonstrate signs and symptoms of meningeal irritation and typically have a brief prodrome of fever and chills. Headache is usually a predominant complaint and may be accompanied by neck stiffness, pharyngitis, and symptoms of upper respiratory tract infections.6
  • Encephalitis
    • This primarily affects children and young adults.
    • Encephalitis can complicate aseptic meningitis or may occur in the absence of meningitis.
    • Focal encephalitis can manifest as a spectrum of signs, including partial motor seizures, hemichorea, and/or acute cerebellar ataxia.
  • Paralysis (and other neurologic complications) of echoviral infections
    • Paralysis caused by nonpolio enteroviruses is usually less severe than that caused by polioviruses.
    • Muscle weakness is more common than flaccid paralysis.
    • Cranial nerve involvement has occasionally been associated with unilateral oculomotor palsy.
    • Guillain-Barré syndrome and transverse myelitis are extremely rare complications of enteroviral infection.6
  • Vesicular rashes
    • Vesicular rashes are similar to lesions of hand-foot-and-mouth disease but occur in crops on the head, trunk, and extremities.
    • Unlike chickenpox, these vesicles do not progress to pustules and scabs. Herpetiform rash caused by echovirus 11 has been reported in immunocompromised adult patients.
    • Petechial and purpuric rashes have been reported with echovirus 9 and coxsackievirus A9 infections. When these rashes have a hemorrhagic component, the illness can be confused with meningococcal disease, particularly when aseptic meningitis occurs.
  • Acute respiratory disease: Enteroviral upper respiratory tract illness is clinically similar to diseases caused by other agents, including rhinovirus, adenovirus, respiratory syncytial virus, and mycoplasma.
  • Herpangina
    • This is characterized by pharyngeal erythema and mild tonsillar exudate.
    • Painful lesions originate as small macules and evolve over a day to erythematous centrally ulcerated papules that are 2-4 mm in diameter. Palatal lesions number no more than 10-12. Pyrexia resolves over 2-4 days, but the enanthem may persist for as long as a week.
  • Pleurodynia
    • Despite its name, pleurodynia is a disease of muscle, not of the pleura or peritoneum. It likely results from direct viral invasion of muscles. In many cases, the pain can be reproduced by pressure on the affected muscles. Palpable, sometimes visible, muscle swelling can be found.
    • It begins abruptly with spasmodic pain, usually involving the lower part of the rib cage or adjacent abdominal area. Pyrexia as high as 39.5°C occurs within 1 hour after the onset of the spasm, subsiding with the pain. Sore throat and headache can occur, but cough and rhinitis are absent.
    • The pain is often poorly localized, and its severity varies substantially. It is described as sticking, lancinating, stabbing, constricting, or viselike. Most commonly, the pain occurs at the costovertebral angle and can be unilateral or bilateral. Adults tend to have more thoracic pain involving the intercostal muscles. Pain may also occur in the upper abdomen or the epigastrium. Periumbilical pain and pain in the lower abdomen is more common in children.
    • Spasmodic pain is characteristic. Chest pain may produce thoracic splinting with shallow rapid respiration.
  • Chronic meningoencephalitis
    • This may develop in hosts who are agammaglobulinemic or otherwise immunocompromised.
    • Enteroviral infections can be associated with considerable morbidity and mortality in immunocompromised hosts. Persistent and sometimes fatal CNS infections have been associated with defective B-lymphocyte function. Most cases occur in children with X-linked agammaglobulinemia.
    • Nervous system manifestations may be totally absent or may present as meningismus, headache, lethargy, papilledema, seizure disorders, motor weakness, tremors, or ataxia. These abnormalities may fluctuate in severity, disappear, or progress steadily.
  • Myopericarditis
    • Enteroviral infections can produce myopericarditis, with severity ranging from asymptomatic disease to intractable heart failure. Sudden death may occur in apparently healthy adults who are later found to have evidence of viral myocarditis at autopsy.
    • Epidemic enteroviral myopericarditis appears to be rare. Most cases have been sporadic, even during enteroviral epidemics.
    • Chest pain occurs in as many as 90% of cases and often is dull in nature. A transient friction rub has been observed in 35%-80% of cases.

Causes

  • Acute aseptic meningitis
    • More than 90% of community-acquired cases of viral meningitis are caused by group B coxsackieviruses or echoviruses. The most common serotypes are group B coxsackievirus serotypes 2-5 and echovirus serotypes 4, 6, 9, 11, 16, and 30.
    • Aseptic meningitis is most commonly associated with echovirus 30.2
  • Encephalitis
    • Enteroviruses, including poliovirus, account for 10%-20% of proven cases of viral encephalitis. This ranks behind arboviruses, herpes simplex virus, and lymphocytic choriomeningitis viruses.
    • Many serotypes have been implicated as causes of encephalitis; coxsackievirus types A9, B2, and B5 and echovirus types 6 and 9 are the serotypes reported most often. The evidence linking each of these serotypes to encephalitis is quite variable.
  • Paralysis and other neurologic complications of echovirus infections
    • Sporadic cases of flaccid motor paralysis are associated with echoviruses 6 and 9.
    • Less frequently implicated serotypes include echoviruses 1-4, 7, 11, 14, 16-18, and 30.
  • Rash
    • The virus can be isolated from the vesicular lesions of patients with hand-foot-and-mouth disease; therefore, these lesions appear to be a direct result of viral invasion of the skin after viremia.
    • Serotypes associated with rubellalike rash include coxsackievirus A9 and echoviruses 2, 4, 11, 19, and 25.
    • Vesicular herpetiform eruptions have been linked to coxsackievirus A9 and echovirus 11.
  • Respiratory tract infection
    • Among the echoviruses, serotype 11 is the most firmly established cause of respiratory disease, although serotypes 4, 8, 9, 20, 22, and 25 may also be causal agents.
    • In volunteers infected experimentally and, occasionally, in patients with naturally acquired disease, some coxsackieviruses and echoviruses may be linked with pneumonia. The role of enteroviruses in lower respiratory illness is not clearly defined; at present, they should be thought of as rare causes of pneumonia.
  • Herpangina: Group A coxsackieviruses (serotypes 1-10, 16, and 22) most commonly are recovered from patients with herpangina. Other less commonly isolated serotypes from herpangina include group B coxsackieviruses 1-5 and echoviruses 3, 6, 9, 16, 17, 25, and 30.
  • Epidemic pleurodynia: Group B coxsackievirus is the most important cause of epidemic pleurodynia. Less common agents implicated as a cause of pleurodynia include some group A coxsackieviruses and echoviruses 1, 6, 9, 16, and 19.
  • Chronic meningoencephalitis
    • This is seen in agammaglobulinemic and immunocompromised hosts.
    • Echoviruses (and polioviruses) can cause persistent and even fatal CNS infections in immunocompromised patients. Picornaviruses require an extracellular phase for cell-to-cell transfer, providing an opportunity for the virus to be inactivated by antibody-mediated mechanisms.
    • Most cases have been caused by echoviruses, including types 5, 6, 7, 11, and 27.
  • Myopericarditis
    • Enteroviruses appear to be the most common viral etiology of acute myopericarditis. In older children and adults, the disease can range from asymptomatic cardiac involvement to intractable heart failure and death.
    • Experimental studies in murine models strongly suggest that viral replication occurs in myocytes and results in myocyte necrosis and focal infiltration by inflammatory cells.
    • A chronic inflammatory process can persist, with variable degrees of fibrosis and loss of myocytes.6

More on Echoviruses

Overview: Echoviruses
Differential Diagnoses & Workup: Echoviruses
Treatment & Medication: Echoviruses
Follow-up: Echoviruses
References

References

  1. Dahllund L, Nissinen L, Pulli T, Hyttinen VP, Stanway G, Hyypiä T. The genome of echovirus 11. Virus Res. Feb 1995;35(2):215-22. [Medline].

  2. Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA. Enterovirus surveillance--United States, 1970-2005. MMWR Surveill Summ. Sep 15 2006;55(8):1-20. [Medline][Full Text].

  3. Oberste MS, Maher K, Flemister MR, Marchetti G, Kilpatrick DR, Pallansch MA. Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol. Mar 2000;38(3):1170-4. [Medline].

  4. Echoviruses of Enteroviruses Infection. virology-online.com. Available at http://virology-online.com/viruses/Enteroviruses6.htm. Accessed 8/31/09.

  5. Ruecker RR. Picornaviridae and their replication. In: Fields BN, Knipe DM, eds. Virology. 2nd ed. New York: Raven Press; 1990:507.

  6. Modlin JF. Coxsackieviruses, echoviruses, and newer enteroviruses. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Vol 2. 6th ed. Philadelphia, PA: Elsevier Inc.; 2005:2148-61.

  7. Kupila L, Vuorinen T, Vainionpäa R, Marttila RJ, Kotilainen P. Diagnosis of enteroviral meningitis by use of polymerase chain reaction of cerebrospinal fluid, stool, and serum specimens. Clin Infect Dis. Apr 1 2005;40(7):982-7. [Medline].

  8. Centers for Disease Control and Prevention (CDC). Aseptic meningitis outbreak associated with echovirus 9 among recreational vehicle campers--Connecticut, 2003. MMWR Morb Mortal Wkly Rep. Aug 13 2004;53(31):710-3. [Medline][Full Text].

  9. Somekh E, Shohat T, Handsher R, Serour F. An outbreak of echovirus 11 in a children's home. Epidemiol Infect. Jun 2001;126(3):441-4. [Medline].

  10. Apisarnthanarak A, Kitphati R, Pongsuwann Y, Tacharoenmueng R, Mundy LM. Echovirus type 11: outbreak of hand-foot-and-mouth disease in a Thai hospital nursery. Clin Infect Dis. Nov 1 2005;41(9):1361-2. [Medline].

  11. Gelfand HM, Holguin AH, Marchetti GE, Feorino PM. A continuing surveillance of enterovirus infections in healthy children in six United States cities. I. Viruses isolated during 1960 and 1961. Am J Hyg. Nov 1963;78:358-75. [Medline].

  12. Wilfert CM, Lauer BA, Cohen M, Costenbader ML, Myers E. An epidemic of echovirus 18 meningitis. J Infect Dis. Jan 1975;131(1):75-8. [Medline][Full Text].

  13. Marier R, Rodriguez W, Chloupek RJ, Brandt CD, Kim HW, Baltimore RS, et al. Coxsackievirus B5 infection and aseptic meningitis in neonates and children. Am J Dis Child. Mar 1975;129(3):321-5. [Medline].

  14. Desmond RA, Accortt NA, Talley L, Villano SA, Soong SJ, Whitley RJ. Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother. Jul 2006;50(7):2409-14. [Medline].

  15. Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M, et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation. Jan 1994;89(1):252-7. [Medline].

  16. Bell EJ, Grist NR. ECHO viruses, carditis, and acute pleurodynia. Am Heart J. Jul 1971;82(1):133-5. [Medline].

  17. Bultmann BD, Eggers HJ, Galle J. Age dependence of paralysis induced by echovirus type 9 in infant mice. J Infect Dis. Jun 1983;147(6):999-1005. [Medline].

  18. CDC. Outbreak of aseptic meningitis associated with multiple enterovirus serotypes--Romania, 1999. MMWR Morb Mortal Wkly Rep. Jul 28 2000;49(29):669-71. [Medline].

  19. Committee on the ECHO Viruses. ENTERIC cytopathogenic human orphan (ECHO) viruses. Science. Dec 16 1955;122(3181):1187-8. [Medline].

  20. Crennan JM, Van Scoy RE, McKenna CH. Echovirus polymyositis in patients with hypogammaglobulinemia. Failure of high-dose intravenous gammaglobulin therapy and review of the literature. Am J Med. Jul 1986;81(1):35-42. [Medline].

  21. Hadfield MG, Seidlin M, Houff SA. Echovirus meningomyeloencephalitis with administration of intrathecal immunoglobulin. J Neuropathol Exp Neurol. Sep 1985;44(5):520-9. [Medline].

  22. Hall CB, Cherry JD, Hatch MH. The return of Boston exanthem. Echovirus 16 infections in 1974. Am J Dis Child. Mar 1977;131(3):323-6. [Medline].

  23. Haynes RE, Cramblett HG, Kronfol HJ. Echovirus 9 meningoencephalitis in infants and children. JAMA. Jun 2 1969;208(9):1657-60. [Medline].

  24. Kaplan GJ, Clark PS, Bender TR. Echovirus type 30 meningitis and related febrile illness: epidemiologic study of an outbreak in an Eskimo community. Am J Epidemiol. Oct 1970;92(4):257-65. [Medline].

  25. Malcom BS, Eiden JJ, Hendley JO. ECHO virus type 9 meningitis simulating tuberculous meningitis. Pediatrics. Apr 1980;65(4):725-6. [Medline].

  26. Modlin JF, Polk BF, Horton P. Perinatal echovirus infection: risk of transmission during a community outbreak. N Engl J Med. Aug 13 1981;305(7):368-71. [Medline].

  27. Spencer FJ. The devil and William Dabney. An epidemiological postscript. JAMA. Feb 21 1966;195(8):645-8. [Medline].

  28. Wilfert CM, Buckley RH, Mohanakumar T. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med. Jun 30 1977;296(26):1485-9. [Medline].

Further Reading

Keywords

echoviruses, enteroviruses, Enterovirus, Picornaviridae, echovirus viremia, acute aseptic meningitis, viral respiratory illness, herpangina, epidemic pleurodynia, myopericarditis, meningoencephalitis, viral paralysis, viral paresis, echovirus, echo virus

Contributor Information and Disclosures

Author

Mary T Busowski, MD, Fellow in Infectious Diseases, Orlando Health; Clinical Instructor of Medicine, Florida State University School of Medicine
Mary T Busowski, MD is a member of the following medical societies: American Academy of Hospice and Palliative Medicine, American College of Physicians, American Medical Association, Florida Medical Association, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Coauthor(s)

Mark R Wallace, MD, FACP, FIDSA, Clinical Professor of Medicine, Florida State University College of Medicine; Infectious Disease Fellowship Director, Orlando Regional Medical Center
Mark R Wallace, MD, FACP, FIDSA is a member of the following medical societies: American College of Physicians, American Medical Association, American Society of Tropical Medicine and Hygiene, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Larry I Lutwick, MD, Professor of Medicine, State University of New York, Downstate Medical School; Director, Infectious Diseases, Veterans Affairs New York Harbor Health Care System, Brooklyn Campus
Larry I Lutwick, MD is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Medical Editor

Mark R Wallace, MD, FACP, FIDSA, Clinical Professor of Medicine, Florida State University College of Medicine; Infectious Disease Fellowship Director, Orlando Regional Medical Center
Mark R Wallace, MD, FACP, FIDSA is a member of the following medical societies: American College of Physicians, American Medical Association, American Society of Tropical Medicine and Hygiene, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Michael Stuart Bronze, MD, Professor, Stewart G Wolf Chair in Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center
Michael Stuart Bronze, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physician Executives, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Medical Association, American Society for Microbiology, Association of Professors of Medicine, Association of Program Directors in Internal Medicine, Infectious Diseases Society of America, Oklahoma State Medical Association, and Southern Society for Clinical Investigation
Disclosure: Nothing to disclose.

CME Editor

Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital
Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital
Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.